Evidence map›Paper›PMID 38445523›Full record

Trial reportHuman brain mapping2024

Effects of dopamine and opioid receptor antagonism on the neural processing of social and nonsocial rewards.

Claudia Massaccesi, Sebastian Korb, Sebastian Götzendorfer, Emilio Chiappini, Matthaeus Willeit, Johan N Lundström, Christian Windischberger, Christoph Eisenegger, Giorgia Silani

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Human brain mapping, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Dopaminergic modulation of social reward anticipation in depression: neural effects of amisulpride versus placebo.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Claudia MassaccesiDepartment of Clinical and Health Psychology, University of Vienna, Vienna, Austria.ORCID 0000-0003-0519-6324
Sebastian KorbDepartment of Cognition, Emotion and Methods in Psychology, University of Vienna, Vienna, Austria.
Sebastian GötzendorferDepartment of Clinical and Health Psychology, University of Vienna, Vienna, Austria.
Emilio ChiappiniDepartment of Clinical and Health Psychology, University of Vienna, Vienna, Austria.
Matthaeus WilleitDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Johan N LundströmDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Christian WindischbergerMR Center of Excellence, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9944-0190
Christoph EiseneggerDepartment of Cognition, Emotion and Methods in Psychology, University of Vienna, Vienna, Austria.
Giorgia SilaniDepartment of Clinical and Health Psychology, University of Vienna, Vienna, Austria.
University of Vienna · ATMedical University of Vienna · ATKarolinska Institutet · SEUniversity of Essex · GB

Funding

Vienna Science and Technology Fund 10.47379/CS15003
6 · The paper itself

Abstract

Rewards are a broad category of stimuli inducing approach behavior to aid survival. Extensive evidence from animal research has shown that wanting (the motivation to pursue a reward) and liking (the pleasure associated with its consumption) are mostly regulated by dopaminergic and opioidergic activity in dedicated brain areas. However, less is known about the neuroanatomy of dopaminergic and opioidergic regulation of reward processing in humans, especially when considering different types of rewards (i.e., social and nonsocial). To fill this gap of knowledge, we combined dopaminergic and opioidergic antagonism (via amisulpride and naltrexone administration) with functional neuroimaging to investigate the neurochemical and neuroanatomical bases of wanting and liking of matched nonsocial (food) and social (interpersonal touch) rewards, using a randomized, between-subject, placebo-controlled, double-blind design. While no drug effect was observed at the behavioral level, brain activity was modulated by the administered compounds. In particular, opioid antagonism, compared to placebo, reduced activity in the medial orbitofrontal cortex during consumption of the most valued social and nonsocial rewards. Dopamine antagonism, however, had no clear effects on brain activity in response to reward anticipation. These findings provide insights into the neurobiology of human reward processing and suggest a similar opioidergic regulation of the neural responses to social and nonsocial reward consumption.

Indexed as

DopamineNarcotic AntagonistsAnimalsEmotionsHumansReceptors, OpioidTouchDopamineNarcotic AntagonistsReceptors, OpioiddopaminefMRIfoodopioidsrewardsocial touch

Identifiers

PMID38445523
PMCPMC10915723
OpenAlexW4392517222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.